Mechanistically, we demonstrate the requisite role of CCR7+ migratory dendritic cells, which necessarily transit through afferent lymphatics to sentinel nodes, for both the clonotypic expansion of antitumor T cells and the successful tumor response to immunoradiotherapy. This evidence concerns the gene CCR7 and neoplasm.